Medical/Pharmaceuticals

Fujifilm Introduces its AI-powered Product for Chest X-ray in Japan, in Collaboration with Lunit

SEOUL, South Korea, Aug. 12, 2021 /PRNewswire/ -- Fujifilm Corporation, a global medical imaging device provider, today announced its AI-powered product for analyzing chest X-ray 'CXR-AID' will be commercially available acrossJapan. CXR-AID is designed to better detect major abnormal findings ...

2021-08-12 20:38 1975

Zhongchao Inc. Builds A Patient DOT Management System

SHANGHAI, China, Aug. 12, 2021 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced that its subsidiary Shanghai Zho...

2021-08-12 20:30 3522

Sri Kota Specialist Medical Centre Honoured at the Asia Pacific Enterprise Awards 2021 Regional Edition

SINGAPORE, Aug. 12, 2021 /PRNewswire/ -- Enterprise Asia, the organiser of the prestigious fifteenth Asia Pacific Enterprise Awards (APEA) 2021 Regional Edition is pleased to recognise 59 exceptional award recipients who have exemplified excellence and perseverance in this unprecedented period. T...

2021-08-12 16:11 1793

UKM collaborated in an international study of mortality rates for babies with birth defects

BANGI, Malaysia, Aug. 12, 2021 /PRNewswire/ -- The Paediatric Surgery Unit of the Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM), sees the culmination of a three-year effort when their international collaborative research found that the survival of a baby born with a birth defect is g...

2021-08-12 08:40 3107

Innovent Announces IBI306 (anti-PCSK-9 antibody) Meets the Primary Endpoint in a Phase 3 Clinical Study for Chinese Heterozygous Familial Hypercholesterolemia

SAN FRANCISCO and SUZHOU, China, Aug. 12, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major dise...

2021-08-12 08:00 8927

Lynk Pharmaceuticals Announced First Patient Dosed in Phase I Clinical Study of Its Triple-Kinase Inhibitor LNK01002

HANGZHOU, China, Aug. 12, 2021 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative drug development company, announced today that it has administered its triple-kinase inhibitor LNK01002 to the first patient in a phase I clinical trial...

2021-08-12 08:00 3173

Dassiet and OrthoPets Collaborate to Provide Safer and Easier Orthopedic Care for Pets

The teams combine Dassiet's clinically proven medical and material innovations with OrthoPets strong experience in custom pet orthoses to provide human level care for animals. ESPOO, Finland and WESTMINSTER, Colo., Aug. 11, 2021 /PRNewswire/ -- The material innovation company Dassiet, and the le...

2021-08-11 21:27 1844

The Former Director of the Center for Drug Evaluation and Research at FDA and R&D Leader at Amgen, Steven Galson Joins Insilico Medicine as Independent Director

HONG KONG, Aug. 11, 2021 /PRNewswire/ -- Insilico Medicine, a global leader in end-to-end AI-powered drug discovery, today announced the appointment ofSteven Galson, MD, MPH as the independent member of the board of directors. "Successful drug development depends on speed and increasing the rates...

2021-08-11 20:31 2326

Sihuan Pharmaceutical (0460.HK): Say "No" to Smuggled Products - Advocate 'Positive Energy' of China's Medical Aesthetics Industry

HONG KONG, Aug. 11, 2021 /PRNewswire/ -- On June 10, 2021, the National Health Commission, leading eight ministries and commissions,  issued the"Notice on Distributing the Special Rectification Work Plan for Combating Illegal Medical Aesthetic Services." On August 9, 2021, 'The People's Daily' pu...

2021-08-11 17:59 3402

Invitation to the presentation of Elekta's first quarter 2021/22

STOCKHOLM, Aug. 11, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the first quarter 2021/22 at10:00 a.m. CEST onAugust 25. The interim report for the first quarter will be published at 7:30 a.m. CEST on the same day. The company's development will be...

2021-08-11 14:16 1711

PT Anugerah Pharmindo Lestari (APL) Won 'Community Initiative' Award and 'Outstanding Leader in Asia' Title for Its President Director at the Asia Corporate Excellence & Sustainability Awards 2021

JAKARTA, Indonesia, Aug. 11, 2021 /PRNewswire/ -- PT Anugerah Pharmindo Lestari (APL), a member of Zuellig Pharma, a leading healthcare services company in Indonesia, has been awarded with the 'Community Initiative' and 'Outstanding Leader inAsia' for APL's President Director, Christophe Piganiol,...

2021-08-11 09:00 1842

Zuellig Pharma Singapore Named 'Industry Champions of the Year' at the Asia Corporate Excellence & Sustainability Awards 2021

SINGAPORE, Aug. 11, 2021 /PRNewswire/ -- Zuellig Pharma Singapore, a leading healthcare services provider inSingapore, has been presented with the 'Industry Champions of the Year' title at the recent Asia Corporate Excellence and Sustainability (ACES) Awards. Held annually, the ACES Awards is a p...

2021-08-11 09:00 2148

Ascensia Presents First Ever Data At Australasian Diabetes Conference 2021 Exploring The Profiles Of Australian Contour®Diabetes App Users

SYDNEY, Aug. 11, 2021 /PRNewswire/ -- Ascensia Diabetes Care, a global diabetes company has today disclosed data at the virtual Australasian Diabetes Conference (ADC) 2021, which takes placeAugust 11-13. The two posters presented for the first time data that analysed CONTOUR®DIABETES App (CDA) us...

2021-08-11 07:00 1642

DERMALOG is one of Germany's most innovative SMEs

Again, DERMALOG has been ranked as one of the most innovative companies in Germany this year. The biometrics company thus ranks in the top group as number 14 of the approximately 4,000 German companies evaluated HAMBURG, Germany, Aug. 10, 2021 /PRNewswire/ -- The German WirtschaftsWoche magazine...

2021-08-10 22:17 5971

Fujifilm Lauded by Frost & Sullivan for Disrupting the Operating Room Space with Its Systems Integration Solution

LONDON, Aug 10, 2021 /PRNewswire/ -- Based on its recent analysis of the global market for operating room (OR) systems integration,Frost & Sullivan recognizes FUJIFILM Medical SystemsUSA, Inc. with the 2021 Global New Product Innovation Award. Its systems integration solution comprising Intellige...

2021-08-10 20:00 1983

Novaliq Completes Enrollment of Second Phase 3 Study for CyclASol® for the Treatment of Dry Eye Disease

HEIDELBERG, Germany and CAMBRIDGE, MA, Aug. 10, 2021 /PRNewswire/ -- Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today announced the second of two Phase 3 (ESSENCE-2) studies, evaluating the inves...

2021-08-10 20:00 1845

Dymicron® Names Gunther Peeters as Senior Vice President of Commercial Operations

Gunther Peeters to spearhead international commercialization of Dymicron's next-generation cervical disc replacement system OREM, Utah, Aug. 10, 2021 /PRNewswire/ -- Dymicron today announced it has appointedGunther Peeters as Senior Vice President of Commercial Operations. With more than 15 year...

2021-08-10 14:17 1101

Orizuru Therapeutics Launches Operations as Research and Development-driven Company for Products Including induced Pluripotent Stem Cell (iPSC) Regenerative Medicine

* Contributing to society and patients through the utilization of iPSC technology developed inJapan * New company to advance two successful outcomes from T-CiRA collaboration for severe heart failure and type I diabetes to clinical application of iPSC-based medicine KYOTO, Japan, Aug. 10, 2...

2021-08-10 14:00 2051

Australia's Cancer Organisations Unite to Urgently Tackle 'Symptom Hesitancy' and Testing 'Rollercoaster' During Pandemic

'New Normal, Same Cancer: Conversations' warns people to get unusual and persistent symptoms checked by their doctor now, to increase detection and improve survival chances, following a slump in cancer testing and screening during the COVID-19 pandemic. * Growing concern among Australian cance...

2021-08-10 04:00 2006

Insilico Medicine Announces an AI-driven PROTAC R&D Collaboration with Arvinas

HONG KONG, Aug. 9, 2021 /PRNewswire/ -- Insilico Medicine is proud to announce an R&D collaboration with Arvinas (NASDAQ: ARVN). This strategic partnership will involve Insilico Medicine's AI-augmented platforms and close cooperation between Arvinas' and Insilico Medicine's scientists on novel PR...

2021-08-09 21:47 2792
1 ... 222223224225226227228 ... 382